Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A phase II study of Anti-PD-L1 Antibody MPDL-3280A(Atezolizumab) in combination with Gemcitabine/Cisplatin in patientswith locally advanced, unresectable, or metastatic biliary cancer.
- Alternative Title
- .
- Authors
- Juneyoung Lee
- Issue Date
- 21-Nov-2015
- Publisher
- 대한항암요법연구회
- Citation
- The 10th KCSG Methodology Workshop
- Conference Name
- The 10th KCSG Methodology Workshop
- Place
- KO
서울대학교 치과병원 제1,2 강의실
- Conference Date
- 2015-11-21
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.